ECS Group, in partnership with Aero Cargo International France and Healthc’Air, has launched a 20-week program designed to significantly upgrade CORSAIR's pharmaceutical cargo management. The comprehensive initiative focuses on developing an audit-ready quality system, which is crucial for handling sensitive pharma shipments.
The program encompasses several key areas, including thorough lane risk assessments, detailed operational reviews, specialized staff training, and the development of robust processes. These measures are intended to enhance shipment control, ensure regulatory compliance, and improve overall service quality for pharmaceutical cargo transported by CORSAIR.
For freight forwarders and their clients, this development means a more secure and compliant option for airfreighting pharmaceuticals. Increased audit readiness and improved operational control can lead to greater reliability in the cold chain, reduced risks of incidents, and smoother customs processes. This enhancement positions CORSAIR as a more competitive and trustworthy carrier for time- and temperature-sensitive medical products, potentially offering forwarders better capacity and service quality on relevant trade lanes.
The ultimate goal is to solidify CORSAIR's standing in the pharmaceutical logistics market by meeting stringent industry standards and customer expectations for pharma cargo.
